# EDGAR Filing Document

**Accession Number:** 0001854794
**File Stem:** 0001085146-25-005246
**Filing Date:** 2025-8
**Character Count:** 10785
**Document Hash:** 72398b7633cfdb069fb0b0f763860991
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001085146-25-005246.hdr.sgml**: 20250814

**ACCESSION NUMBER**: 0001085146-25-005246

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250814

**DATE AS OF CHANGE**: 20250814

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Canada Goose Holdings Inc.
- **CENTRAL INDEX KEY:** 0001690511
- **STANDARD INDUSTRIAL CLASSIFICATION:** APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-89926
- **FILM NUMBER:** 251218434

**BUSINESS ADDRESS:**
- **STREET 1:** 250 BOWIE AVENUE
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M6E 4Y2
- **BUSINESS PHONE:** 416-780-9850

**MAIL ADDRESS:**
- **STREET 1:** 250 BOWIE AVENUE
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M6E 4Y2

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Canada Goose Holdings, Inc.
- **DATE OF NAME CHANGE:** 20161118
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Patient Capital Management, LLC
- **CENTRAL INDEX KEY:** 0001854794

**ORGANIZATION NAME:**
- **EIN:** 844277115
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G/A

**BUSINESS ADDRESS:**
- **STREET 1:** ONE SOUTH STREET, SUITE 2101
- **CITY:** BALTIMORE
- **STATE:** MD
- **ZIP:** 21202
- **BUSINESS PHONE:** 410-454-3130

**MAIL ADDRESS:**
- **STREET 1:** ONE SOUTH STREET, SUITE 2101
- **CITY:** BALTIMORE
- **STATE:** MD
- **ZIP:** 21202

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**(Amendment No. 3)**

**Issuer:** Canada Goose Holdings Inc.

**Title of Class of Securities:** Common Stock

**CUSIP Number:** 135086106

**Date of Event Which Requires Filing of this Statement:** 06/30/2025

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [x] Rule 13d-1(b)

- [ ] Rule 13d-1(c)

- [ ] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>Patient Capital Management, LLC | Names of Reporting Persons<br>Patient Capital Management, LLC |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>735183 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>0 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>735183 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>735183 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>1.6% | Percent of Class Represented by Amount in Row (9)<br>1.6% |
| 12. | Type of Reporting Person (See Instructions)<br>IA | Type of Reporting Person (See Instructions)<br>IA |

---

| 1. | Names of Reporting Persons<br>Patient Opportunity Trust, a series of Advisor Managed Portfolios | Names of Reporting Persons<br>Patient Opportunity Trust, a series of Advisor Managed Portfolios |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>300000 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>0 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>300000 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>300000 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>0.65% | Percent of Class Represented by Amount in Row (9)<br>0.65% |
| 12. | Type of Reporting Person (See Instructions)<br>IV | Type of Reporting Person (See Instructions)<br>IV |

**Comment for Type of Reporting Person:** 1) Patient Capital Management, LLC is deemed to be the beneficial owner of 2,671,192 shares of common stock.
2) Patient Opportunity Trust is deemed to be beneficial owner of 1,903,482 shares of common stock.

---

**Item 1(a). Name of Issuer:**
Canada Goose Holdings Inc.

**Item 1(b). Address of Issuer's Principal Executive Offices:**
250 BOWIE AVENUE, TORONTO, CANADA (FEDERAL LEVEL)
M6E 4Y2

**Item 2(a). Name of Person Filing:**
Patient Capital Management, LLC

Patient Opportunity Trust, a series of Advisor Managed Portfolios

**Item 2(b). Address of Principal Business Office:**
ONE SOUTH STREET, SUITE 2550
BALTIMORE, Maryland
21202

**Item 2(c). Citizenship:**
Patient Capital Management, LLC - DELAWARE

Patient Opportunity Trust, a series of Advisor Managed Portfolios - DELAWARE

**Item 2(d). Title of Class of Securities:**
Common Stock

**Item 2(e). CUSIP Number:**
135086106

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [x] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

735,183

**(b) Percent of class:**

1.60

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

Patient Capital Management, LLC - 735,183
Patient Opportunity Trust, a series of Advisor Managed Portfolios - 300,000

**(ii) Shared power to vote or to direct the vote:**

Patient Capital Management, LLC - 0
Patient Opportunity Trust, a series of Advisor Managed Portfolios - 0

**(iii) Sole power to dispose or to direct the disposition of:**

Patient Capital Management, LLC - 0
Patient Opportunity Trust, a series of Advisor Managed Portfolios - 0

**(iv) Shared power to dispose or to direct the disposition of:**

Patient Capital Management, LLC - 0
Patient Opportunity Trust, a series of Advisor Managed Portfolios - 0

**Item 5. Ownership of Five Percent or Less of a Class.**

[x] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

Various accounts managed by Patient Capital Management, LLC have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities. The interest of one account, Patient Opportunity Trust, a series of Advisor Managed Portfolios, an investment company registered under the Investment Company Act of 1940 and managed by Patient Capital Management, LLC was deemed to be the beneficial owner of 735,183 shares or 1.60% of the total shares outstanding as of December 31, 2024.  Patient Opportunity Trust was deemed to be the beneficial owners of 300,000 shares or 0.65 percent of total shares outstanding as of March 31, 2025.

**Item 7. Identification and Classification of the Subsidiary**

Not Applicable

**Item 8. Identification and Classification of Members of the Group**

Not Applicable

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Patient Capital Management, LLC**

**Date:** 07/21/2025

**By:** Milton Dodge

**Name & Title:** Chief Compliance Officer

**Patient Opportunity Trust, a series of Advisor Managed Portfolios**

**Date:** 07/21/2025

**By:** Russell B. Simon

**Name & Title:** President